(JBI) Janus International - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US47103N1063
Stock: Doors, Hallway Systems, Storage Units, Automation
Total Rating 26
Risk 91
Buy Signal 0.39
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 45.6% |
| Relative Tail Risk | -8.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.08 |
| Alpha | -25.57 |
| Character TTM | |
|---|---|
| Beta | 0.915 |
| Beta Downside | 0.948 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.71% |
| CAGR/Max DD | -0.21 |
Description: JBI Janus International January 16, 2026
Janus International Group, Inc. (NYSE:JBI) designs, manufactures, and installs turn-key storage and industrial building solutions across North America and select international markets. Its product portfolio includes roll-up and swing doors, hallway systems, relocatable storage units, and integrated automation and access-control technologies. Founded in 2002 and based in Temple, Georgia, the company serves the self-storage, commercial, and industrial sectors.
Key metrics and drivers: • FY 2023 revenue reached approximately $1.1 billion, reflecting a 7 % year-over-year increase driven by strong demand for self-storage expansion. • The U.S. self-storage market grew at a 5 % CAGR over the past five years, buoyed by urbanization, housing affordability pressures, and a shift toward “just-in-time” inventory storage for e-commerce firms. • Capital-expenditure cycles in commercial construction and a broader industry push toward automated access solutions are expected to sustain demand for Janus’s high-margin door-automation products.
For a deeper quantitative look at JBI’s valuation metrics, you might find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 47.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -0.93 > 1.0 |
| NWC/Revenue: 31.18% < 20% (prev 24.19%; Δ 6.99% < -1%) |
| CFO/TA 0.13 > 3% & CFO 166.1m > Net Income 47.0m |
| Net Debt (370.1m) to EBITDA (154.7m): 2.39 < 3 |
| Current Ratio: 3.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.4m) vs 12m ago -3.36% < -2% |
| Gross Margin: 39.16% > 18% (prev 0.43%; Δ 3873 % > 0.5%) |
| Asset Turnover: 68.48% > 50% (prev 76.97%; Δ -8.49% > 0%) |
| Interest Coverage Ratio: 2.83 > 6 (EBITDA TTM 154.7m / Interest Expense TTM 38.7m) |
Altman Z'' 3.34
| A: 0.21 (Total Current Assets 413.8m - Total Current Liabilities 136.7m) / Total Assets 1.30b |
| B: 0.27 (Retained Earnings 351.0m / Total Assets 1.30b) |
| C: 0.08 (EBIT TTM 109.4m / Avg Total Assets 1.30b) |
| D: 0.47 (Book Value of Equity 349.5m / Total Liabilities 739.7m) |
| Altman-Z'' Score: 3.34 = A |
Beneish M -3.27
| DSRI: 0.86 (Receivables 142.8m/186.1m, Revenue 888.7m/996.8m) |
| GMI: 1.09 (GM 39.16% / 42.64%) |
| AQI: 0.93 (AQ_t 0.58 / AQ_t-1 0.63) |
| SGI: 0.89 (Revenue 888.7m / 996.8m) |
| TATA: -0.09 (NI 47.0m - CFO 166.1m) / TA 1.30b) |
| Beneish M-Score: -3.27 (Cap -4..+1) = AA |
What is the price of JBI shares?
As of February 08, 2026, the stock is trading at USD 7.27 with a total of 1,080,613 shares traded.
Over the past week, the price has changed by +5.98%, over one month by +5.21%, over three months by +5.36% and over the past year by -11.88%.
Over the past week, the price has changed by +5.98%, over one month by +5.21%, over three months by +5.36% and over the past year by -11.88%.
Is JBI a buy, sell or hold?
Janus International has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy JBI.
- StrongBuy: 2
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.3 | 27.9% |
| Analysts Target Price | 9.3 | 27.9% |
| ValueRay Target Price | 7.2 | -0.8% |
JBI Fundamental Data Overview February 03, 2026
P/E Trailing = 20.1765
P/E Forward = 13.5685
P/S = 1.0721
P/B = 1.7031
Revenue TTM = 888.7m USD
EBIT TTM = 109.4m USD
EBITDA TTM = 154.7m USD
Long Term Debt = 540.3m USD (from longTermDebt, last quarter)
Short Term Debt = 8.70m USD (from shortTermDebt, last quarter)
Debt = 549.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 370.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.32b USD (952.8m + Debt 549.0m - CCE 178.9m)
Interest Coverage Ratio = 2.83 (Ebit TTM 109.4m / Interest Expense TTM 38.7m)
EV/FCF = 9.44x (Enterprise Value 1.32b / FCF TTM 140.1m)
FCF Yield = 10.59% (FCF TTM 140.1m / Enterprise Value 1.32b)
FCF Margin = 15.76% (FCF TTM 140.1m / Revenue TTM 888.7m)
Net Margin = 5.29% (Net Income TTM 47.0m / Revenue TTM 888.7m)
Gross Margin = 39.16% ((Revenue TTM 888.7m - Cost of Revenue TTM 540.7m) / Revenue TTM)
Gross Margin QoQ = 39.08% (prev 40.86%)
Tobins Q-Ratio = 1.02 (Enterprise Value 1.32b / Total Assets 1.30b)
Interest Expense / Debt = 1.58% (Interest Expense 8.70m / Debt 549.0m)
Taxrate = 28.64% (6.10m / 21.3m)
NOPAT = 78.1m (EBIT 109.4m * (1 - 28.64%))
Current Ratio = 3.03 (Total Current Assets 413.8m / Total Current Liabilities 136.7m)
Debt / Equity = 0.98 (Debt 549.0m / totalStockholderEquity, last quarter 560.8m)
Debt / EBITDA = 2.39 (Net Debt 370.1m / EBITDA 154.7m)
Debt / FCF = 2.64 (Net Debt 370.1m / FCF TTM 140.1m)
Total Stockholder Equity = 537.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.62% (Net Income 47.0m / Total Assets 1.30b)
RoE = 8.74% (Net Income TTM 47.0m / Total Stockholder Equity 537.5m)
RoCE = 10.15% (EBIT 109.4m / Capital Employed (Equity 537.5m + L.T.Debt 540.3m))
RoIC = 7.11% (NOPAT 78.1m / Invested Capital 1.10b)
WACC = 6.31% (E(952.8m)/V(1.50b) * Re(9.29%) + D(549.0m)/V(1.50b) * Rd(1.58%) * (1-Tc(0.29)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.61%
[DCF Debug] Terminal Value 86.99% ; FCFF base≈144.7m ; Y1≈178.5m ; Y5≈304.0m
Fair Price DCF = 53.33 (EV 7.77b - Net Debt 370.1m = Equity 7.40b / Shares 138.8m; r=6.31% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -56.25 | EPS CAGR: -44.34% | SUE: -2.65 | # QB: 0
Revenue Correlation: -46.97 | Revenue CAGR: -1.86% | SUE: -0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=-0.020 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.64 | Chg30d=+0.000 | Revisions Net=-4 | Growth EPS=+9.5% | Growth Revenue=+1.6%
P/E Forward = 13.5685
P/S = 1.0721
P/B = 1.7031
Revenue TTM = 888.7m USD
EBIT TTM = 109.4m USD
EBITDA TTM = 154.7m USD
Long Term Debt = 540.3m USD (from longTermDebt, last quarter)
Short Term Debt = 8.70m USD (from shortTermDebt, last quarter)
Debt = 549.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 370.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.32b USD (952.8m + Debt 549.0m - CCE 178.9m)
Interest Coverage Ratio = 2.83 (Ebit TTM 109.4m / Interest Expense TTM 38.7m)
EV/FCF = 9.44x (Enterprise Value 1.32b / FCF TTM 140.1m)
FCF Yield = 10.59% (FCF TTM 140.1m / Enterprise Value 1.32b)
FCF Margin = 15.76% (FCF TTM 140.1m / Revenue TTM 888.7m)
Net Margin = 5.29% (Net Income TTM 47.0m / Revenue TTM 888.7m)
Gross Margin = 39.16% ((Revenue TTM 888.7m - Cost of Revenue TTM 540.7m) / Revenue TTM)
Gross Margin QoQ = 39.08% (prev 40.86%)
Tobins Q-Ratio = 1.02 (Enterprise Value 1.32b / Total Assets 1.30b)
Interest Expense / Debt = 1.58% (Interest Expense 8.70m / Debt 549.0m)
Taxrate = 28.64% (6.10m / 21.3m)
NOPAT = 78.1m (EBIT 109.4m * (1 - 28.64%))
Current Ratio = 3.03 (Total Current Assets 413.8m / Total Current Liabilities 136.7m)
Debt / Equity = 0.98 (Debt 549.0m / totalStockholderEquity, last quarter 560.8m)
Debt / EBITDA = 2.39 (Net Debt 370.1m / EBITDA 154.7m)
Debt / FCF = 2.64 (Net Debt 370.1m / FCF TTM 140.1m)
Total Stockholder Equity = 537.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.62% (Net Income 47.0m / Total Assets 1.30b)
RoE = 8.74% (Net Income TTM 47.0m / Total Stockholder Equity 537.5m)
RoCE = 10.15% (EBIT 109.4m / Capital Employed (Equity 537.5m + L.T.Debt 540.3m))
RoIC = 7.11% (NOPAT 78.1m / Invested Capital 1.10b)
WACC = 6.31% (E(952.8m)/V(1.50b) * Re(9.29%) + D(549.0m)/V(1.50b) * Rd(1.58%) * (1-Tc(0.29)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.61%
[DCF Debug] Terminal Value 86.99% ; FCFF base≈144.7m ; Y1≈178.5m ; Y5≈304.0m
Fair Price DCF = 53.33 (EV 7.77b - Net Debt 370.1m = Equity 7.40b / Shares 138.8m; r=6.31% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -56.25 | EPS CAGR: -44.34% | SUE: -2.65 | # QB: 0
Revenue Correlation: -46.97 | Revenue CAGR: -1.86% | SUE: -0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=-0.020 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=0.64 | Chg30d=+0.000 | Revisions Net=-4 | Growth EPS=+9.5% | Growth Revenue=+1.6%